Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Markets Trade in the Red
Mon, 9 Nov 11:30 am

After opening the day deep in the red, the Indian Indices capped some gains but failed to inch enough upwards and continued to trade negatively. Sectoral indices are trading on a discouraging note with stocks from the pharma, banking and capital goods sector witnessing maximum selling pressure.

The BSE-Sensex is trading down 299 points (down 1.1%) and the NSE-Nifty is trading down 90 points (down 1.1%). The BSE Mid Cap index is trading marginally higher and the BSE Small Cap index is trading up 0.4%. The rupee is trading at 66.38 to the US$.

India's leading pharma company Sun Pharma has announced its results for the second quarter ended September 30, 2015 (2QFY15). The net sales during the quarter declined by 15% YoY to Rs 68 billion. The sales decline was due to supply constraints and higher base sales in US during 2QFY15. The company had benefited from one 180-days exclusivity launch during this period. The company has reported a 46% year on year (YoY) decline in its consolidated net profit to Rs 11 billion for the quarter on a. The sharp plunge was on the back of lower sales growth, volatile currency movements and supply constraints.

Sale of branded formulations in India for the quarter rose 1% YoY and accounted for nearly 26% of total sales. Sales in the US were US$ 510 million, down 28% YoY and accounted for 48% of total sales. Sales in the emerging markets fell 16% YoY and accounted for 13% of total sales. External sales of active pharmaceutical ingredients rose 13% YoY to Rs 3 billion.

As per the management, the company continues to invest significantly in enhancing its specialty and complex generics pipeline. Further, the management has stated that the integration of Ranbaxy is progressing well and the benefits of certain costs incurred will be visible in the successive months. The firm is also evaluating opportunities to expand its global footprint. In the past, Sun Pharma has done various acquisitions and has been able to turn them around as well. The company's recent acquisition of Ranbaxy is expected to bring around US$ 300 miliion in next 2-3 years. These synergies are expected to improve the company's margins going forward.

Presently the stock of Sun Pharma is trading down by 4.6%.

Banking stocks are trading negatively with IDFC Bank and ICICI Bank witnessing maximum selling pressure. As per a leading financial daily, the newest private sector lender in India IDFC Bank is aiming to fill the space being left by the inability of state-run banks to expand their balance sheet due to capital constraints.

With this opening, the bank will be gearing up to build up its retail franchise. Initially, the bank will be focusing on the non-core income side to accrue capital which it hopes to pump back for rural play. Of the 23 branches opened by the bank so far, 15 are in rural areas of Madhya Pradesh. The retail expansion, especially in rural areas, will take some time as it needs to shore up capital.

Further, the bank has planned to reinvest some profits generated from wholesale and commercial banking into building its rural franchise and a personal and business banking franchise. The bank, regarding the personal and business banking has stated that it will be focused on top 50 centres as 80% of corporate and household savings rely on these 50 centres.

Presently, public sector banks are going through many concerns and are expected to remain significantly capital-constrained in the future. This has opened the doors for many private sector banks in expanding their footprint. However, success in this regard depends on the implementation of programmes by private banks. Only time will tell which ones will really benefit from this opportunity.

Infrastructure Development Finance Company Ltd (IDFC) is India's leading integrated infrastructure finance player providing end to end infrastructure financing and project implementation services. The company's main business is to provide finance for infrastructure projects including through ownership of infrastructure assets. Its scrip is currently trading down by 4.5%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian Markets Trade in the Red". Click here!


Views on News

Inflation & Your Investments (Fast Profits Daily)

Mar 4, 2021

Inflation is the buzz word in the world of finance these days. It impacts all of us. Here's how it affects your investments.

What India's Positive GDP Reading Means for Your Equity Mutual Fund Investments (Outside View)

Mar 4, 2021

Given the risks involved, we may witness a sort of 'W-shaped' recovery wherein we would dip again before moving up, explains Rounaq Neroy in this edition of the Daily Wealth Letter.

I'm Back to Where It All Started (Profit Hunter)

Mar 4, 2021

Join us in welcoming research analyst, Aditya Vora, to Equitymaster.

Dollar at 80? (Fast Profits Daily)

Mar 3, 2021

Can the rupee depreciate to 80 against the US dollar? In this video, I'll show you what the charts say.

Motilal Oswal Asset Allocation Passive Fund of Fund: Aims to Benefit from Investing in Multi-Asset Passive Funds (Outside View)

Mar 3, 2021

PersonalFN analyses the features of Motilal Oswal Asset Allocation Passive Fund of Fund and explains the potential this fund has to offer to its investors.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...


India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms


Mar 4, 2021 (Close)